Skip to main content

Animations

MJFF Publications

6301 - 6310 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2019
  • 2024
  • 2019
  • 2023
  • 2015
  • 2018
  • 2024
  • 2015
  • 2023
  • Summary Details
    OPEN
    Title: Differentially expressed genes in Alzheimer’s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1
    Journal Name: Brain, Behavior, & Immunity - Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.bbih.2021.100227
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.102111
    Citation Count: 36
  • Summary Details
    RESTRICTED
    Title: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2019.08.010
    Citation Count: 182
  • Summary Details
    RESTRICTED
    Title: Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    Journal Name: NEJM Evidence
    Publisher: Massachusetts Medical Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1056/evidoa2200311
    Citation Count: 19
  • Summary Details
    OPEN
    Title: The Discovery of Central Nervous System Lymphatic Vessels: The Missing Link That Closes the Circle of Brain Immunosurveillance
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12282
    Citation Count: 1
  • Summary Details
    OPEN
    Title: β2‐adrenoreceptor medications and risk of Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25341
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Neural heterogeneity controls computations in spiking neural networks
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2311885121
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2015.11.007
    Citation Count: 122
  • Summary Details
    OPEN
    Title: Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad025
    Citation Count: 15
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.